Floatz logo

Therapeutic Asset Ratings

615 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Palbociclib
Hormone-Resistant Breast Carcinoma
Fudan UniversityN/AD (30)
Pralsetinib, trans-
Pralsetinib
Fudan UniversityN/AD (30)
PROPOFOL
NETs
Fudan UniversityN/AD (30)
PROPOFOL
Opioid-free Anesthesia
Fudan UniversityN/AD (30)
RAMIFENTANYL
NETs
Fudan UniversityN/AD (30)
RAMIFENTANYL
Opioid-free Anesthesia
Fudan UniversityN/AD (30)
Rapamycin
Hormone-Resistant Breast Carcinoma
Fudan UniversityN/AD (30)
Rocuronium
NETs
Fudan UniversityN/AD (30)
Rocuronium
Opioid-free Anesthesia
Fudan UniversityN/AD (30)
ROPIVACAINE
NETs
Fudan UniversityN/AD (30)
ROPIVACAINE
Opioid-free Anesthesia
Fudan UniversityN/AD (30)
S-Ketamine
NETs
Fudan UniversityN/AD (30)
S-Ketamine
Opioid-free Anesthesia
Fudan UniversityN/AD (30)
SUFENTANYL
NETs
Fudan UniversityN/AD (30)
SUFENTANYL
Opioid-free Anesthesia
Fudan UniversityN/AD (30)
FLURBIPROFEN
Colorectal Cancer
Fudan UniversityN/AD (26)
Leucogen
Non-Small Cell Lung Carcinoma
Fudan UniversityN/AD (26)
RAMIFENTANYL
Colorectal Cancer
Fudan UniversityN/AD (26)
Rocuronium
Colorectal Cancer
Fudan UniversityN/AD (26)
S-Ketamine
Colorectal Cancer
Fudan UniversityN/AD (26)
SUFENTANYL
Colorectal Cancer
Fudan UniversityN/AD (26)
Huaier Granule
Invasive Ductal Breast Carcinoma
Fudan UniversityP4NR (0)
Pcbhp
Breast Cancer
Fudan UniversityP3NR (0)
Thymosin Alpha 1
Colorectal Carcinoma
Fudan UniversityP3NR (0)
Adrelumab
Breast Carcinoma
Fudan UniversityP2NR (0)
Showing 576 to 600 of 615 assets
PreviousPage 24 of 25Next